54 results
POS AM
13erg5
3 Mar 22
Prospectus update (post-effective amendment)
8:29am
8-K
EX-99.1
nxorjpiv
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
POSASR
j82p1h
3 Mar 22
Automatic shelf registration (post-effective amendment)
7:00am
8-K
xaywv6c33jw7iw
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
EX-99.1
tou1usnzfg6ad9
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am